MICHAEL VOLK to United States
This is a "connection" page, showing publications MICHAEL VOLK has written about United States.
Connection Strength
0.478
-
Patient-centered care: Key elements applicable to chronic liver disease. Hepatology. 2023 07 01; 78(1):307-318.
Score: 0.070
-
Constitutional Challenges to Liver Transplant Policy. Transplantation. 2019 11; 103(11):e378-e381.
Score: 0.058
-
A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology. 2019 03; 69(3):1300-1305.
Score: 0.055
-
Trends in hepatitis C treatment uptake in the United States. Hepatology. 2014 Aug; 60(2):768-9.
Score: 0.040
-
Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012 Jan; 55(1):184-91.
Score: 0.034
-
Can quality of care for patients with cirrhosis be measured? Dig Dis Sci. 2011 Dec; 56(12):3488-91.
Score: 0.033
-
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009 Dec; 50(6):1750-5.
Score: 0.029
-
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
Score: 0.027
-
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 09 01; 80(3):742-753.
Score: 0.020
-
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 07; 76(1):251-274.
Score: 0.017
-
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 05; 75(5):1289-1299.
Score: 0.017
-
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
Score: 0.016
-
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019 05; 156(6):1675-1682.
Score: 0.014
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.014
-
The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018 09; 68(3):872-882.
Score: 0.013
-
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
Score: 0.012
-
Improving quality of health care for patients with cirrhosis. Gastroenterology. 2014 Dec; 147(6):1204-7.
Score: 0.010